Week 5 Psy 480
Psy/480
Week 5 portion
1: Prescription Privileges Some of the current changes that can be seen in regards to prescription privileges include changes in the ways that physicians and mental health professionals are able to prescribe medications to their patients. According to Brenda Smith of the APA (2012), currently patients receive their medications for psychological conditions by a physician usually without having been evaluated by a mental health practitioner according to the CDC. The trend includes individuals to visit their general health practitioners in order to receive psychotropic medications such as antidepressants and anxiolytics. The problem with individuals receiving these medications from other sources include: deterrence from alternate treatment interventions that include CBT or psychoanalysis. Changes currently described as happening in the realm of prescription privileges include the expansion of prescription writing privileges to mental health professional such as license psychologists that are well-versed in psychopharmacology as well as the dangers of overuse and over prescription of psychotropic medications. According to the American psychological Association (Smith, 2012), several states programs for psychologists designed in respect to prescription privileged programs have been approved. The states include Louisiana, New Mexico and the US armed forces. Additionally according to the American psychological Association (Smith, 2012), there are several bills being considered in many other states regarding the expansion of prescription drug privileges but many of these measures have been met by opposition from the American Medical Association and the American psychiatric Association due to concerns about the adequacy of each training programs in dispensing of prescription medication and overall patient safety.
2. Changes in Ethics of Drug Treatment
Some of the decisive changes described above in the ethical use of drug treatments for
Week 5 portion
1: Prescription Privileges Some of the current changes that can be seen in regards to prescription privileges include changes in the ways that physicians and mental health professionals are able to prescribe medications to their patients. According to Brenda Smith of the APA (2012), currently patients receive their medications for psychological conditions by a physician usually without having been evaluated by a mental health practitioner according to the CDC. The trend includes individuals to visit their general health practitioners in order to receive psychotropic medications such as antidepressants and anxiolytics. The problem with individuals receiving these medications from other sources include: deterrence from alternate treatment interventions that include CBT or psychoanalysis. Changes currently described as happening in the realm of prescription privileges include the expansion of prescription writing privileges to mental health professional such as license psychologists that are well-versed in psychopharmacology as well as the dangers of overuse and over prescription of psychotropic medications. According to the American psychological Association (Smith, 2012), several states programs for psychologists designed in respect to prescription privileged programs have been approved. The states include Louisiana, New Mexico and the US armed forces. Additionally according to the American psychological Association (Smith, 2012), there are several bills being considered in many other states regarding the expansion of prescription drug privileges but many of these measures have been met by opposition from the American Medical Association and the American psychiatric Association due to concerns about the adequacy of each training programs in dispensing of prescription medication and overall patient safety.
2. Changes in Ethics of Drug Treatment
Some of the decisive changes described above in the ethical use of drug treatments for
References: Cooper, W., Arbogast, P., & Ding, H. (2006, March). Trends in prescribing antipsychotic medications in US children. Ambulatory Pediatrics: the official journal of the Ambulatory Pediatrics Association, 6(2). Tietz, G. F. (1986, April). Informed consent in the prescription drug context: the special case. Washington Law Review, 61(367). Smith, B. L. (2012, June). Inappropriate Prescribing. American Psychological Association, 43(6), 36.